Ipamorelina
Selective GH secretagogue (ghrelin receptor / GHS-R agonist)
Selective secretagogue that stimulates pulsatile GH release.
Back to technical sheets- Class
- Selective GH secretagogue (ghrelin receptor / GHS-R agonist)
- Also known as
- Not approved for general clinical use
Mechanism of action
Ghrelin receptor (GHS-R) agonist that stimulates growth-hormone release with relative selectivity, without markedly raising cortisol or prolactin.
Evidence
Preclinical studies and some early safety/pharmacokinetic trials. Not approved for general clinical use. Investigational.
Studied uses
- GH stimulation (research contexts)
Safety considerations
- Stimulating the somatotropic axis is not harmless
- Limited long-term safety data
- Not approved for general human use
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Purity
- ≥ 99 % (HPLC)
- Net content
- 85 %
- Batch
- IPA-2601
- Presentation
- Polvo liofilizado en vial sellado
Net content is the fraction of the vial’s weight that is actually peptide, after discounting water, salts and excipients. It is the figure to calculate with, not the label weight.
Sample prices and batch data while the real ones are loaded.
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.